S.1. Theoretical Calculations for the number of nanoparticles (bMSNs)
Theoretical calculations to determine the number of nanoparticles per gram were based on a previously reported procedure. [1] Volume of a mesoporous nanoparticle, such as bMSN can be divided into (i) pore volume, (V p ) and solid volume (V s ). V p was determined from the BET data, while Vs was determined using The theoretically calculated number was found to be very close to that determined using the NanoSight Technology ~8.97 × 10 11 bMSNs mL -1 or 3.59× 10 14 g -1 .
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S.2. Calculation of the number of silanol groups per bMSN
According to the Zhuravlev model, the number of silanol groups (Si-OH) per unit surface area of amorphous silica is depicted by a physico-chemical constant (known as the Kiselev-Zhuravlev constant) with a numerical value ~4.9 nm -2 . [2] The number of silanol groups for bMSN (5 v/v%), thus calculated is presented in Table S1 .
S.3. Calculation of the number of targeting ligands (TRC105) per bMSN
Prior to conjugation, TRC105 was derivatized with Traut's Reagent, such that each antibody molecule possessed ~3 -SH moieties (as determined by the Ellman's Reagent test). [3] Initial amount of TRC105-SH added to the nanoparticle solution = 45.80 µg or 1.83 × 10 14 molecules.
After incubation with bMSN-PEG 5k -Mal (~8.97 × 10 11 mL -1 ) for 3 h, the solution was centrifuged at 5000g to remove any unconjugated antibody. Amount of unreacted TRC105-SH in the supernatant was calculated from the Bradford Assay using the standard curve after polynomial fitting ( Figure S4 ). Amount of unreacted TRC105-SH was determined to be ~35.82
µg. Thus, ~4.02 × 10 13 molecules of TRC105-SH were finally conjugated to the bMSN-PEG 5k -Mal. Considering the number of nanoparticles per reaction to be ~8.97 × 10 11 mL -1 , the number of TRC105-SH conjugated per nanoparticle per mL was determined to be ~44.6.
S.4. Prediction of elimination half-life (t 1/2β ) of [ 89 Zr]bMSN-PEG 5k -TRC105
Elimination half-life (t 1/2β ) of [ 89 Zr]bMSN-PEG 5k -TRC105 was roughly estimated using the quantification data obtained from serial PET scans in 4T1 tumor bearing mice (n = 4). Equal volume regions-of-interest (ROIs) were drawn over the heart tissue in the PET images and used to calculate percentage injected dose per gram of tissue (%ID/g) at each time-point. All data was decay corrected and processed as previously described. [4] Bi-exponential fitting of the timeactivity curve was used to estimate t 1/2β of [ 89 Zr]bMSN-PEG 5k -TRC105 ( Figure S7 ). Figure S1 . Size-Concentration graph for 1000-times diluted solution of bMSN (5 v/v%). 
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